Patents by Inventor Youlin Qi

Youlin Qi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240102042
    Abstract: The invention provides novel recombinant DNA molecules, compositions, and methods for selectively regulating the expression of a transcribable polynucleotide molecule or recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides transgenic plants, plant cells, plant parts, seeds, and commodity products comprising such DNA molecules and compositions.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 28, 2024
    Inventors: Jintai Huang, Youlin Qi, Heping Yang, Yuanji Zhang
  • Patent number: 11866721
    Abstract: The invention provides novel recombinant DNA molecules, compositions, and methods for selectively regulating the expression of a transcribable polynucleotide molecule or recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides transgenic plants, plant cells, plant parts, seeds, and commodity products comprising such DNA molecules and compositions.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: January 9, 2024
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: Jintai Huang, Youlin Qi, Heping Yang, Yuanji Zhang
  • Publication number: 20230392162
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Application
    Filed: December 1, 2022
    Publication date: December 7, 2023
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang
  • Publication number: 20230192865
    Abstract: Provided is a nano antibody, the amino acid sequence thereof being EVQLQASGGGFVQPGGSLRLSCAASGFTFSSX1AMGWFRQAPGKEREX2VSAISSGGGNTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCVTPGGRLWYYRYDYRCQGTQVTVSS (SEQ ID NO: 1), where X1 is selected from Y or F, and X2 is selected from F or L. The antibody can be used to dissolve Charcot-Leyden crystals (CLCs), thereby reducing pulmonary inflammation, changes in lung function, and mucus production. Further provided is the use of the nano antibody in the preparation of a drug and a reagent for testing Charcot-Leyden crystals (CLCs) and/or Galectin-10 protein.
    Type: Application
    Filed: May 6, 2020
    Publication date: June 22, 2023
    Inventors: Zhe SONG, Youlin QI, Yaobin QIN, Jianfeng YANG, Limin HOU, Zhiwei ZHU, Qiuping DONG, Xianggan LI, Lei ZHANG, Jinyu WANG, Yuejin LI
  • Publication number: 20230037341
    Abstract: The invention provides transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products derived from event MON 87427. The invention also provides nucleotides specific for transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products comprising nucleotides specific for transgenic maize event MON 87427. The invention also provides methods related to transgenic maize event MON 87427 and to the Roundup® Hybridization System (RHS). The invention also provides a Relative Development Scale useful for monitoring and determining reproductive development in maize that reconciles developmental differences across various maize varieties. This is useful for determining the optimal timing of a treatment regimen in which tassel development stage is an important factor, including various methods in making hybrid seed.
    Type: Application
    Filed: August 2, 2022
    Publication date: February 9, 2023
    Inventors: Paul C. C. Feng, Agustin E. Fonseca, Carl W. Garnaat, Oscar Heredia, Jintai Huang, Rebecca A. Kelly, Youlin Qi, Martin A. Stoecker
  • Patent number: 11560574
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: January 24, 2023
    Assignee: MONSANTO TECHNOLOGY LLC
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang
  • Patent number: 11441155
    Abstract: The invention provides transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products derived from event MON 87427. The invention also provides nucleotides specific for transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products comprising nucleotides specific for transgenic maize event MON 87427. The invention also provides methods related to transgenic maize event MON 87427 and to the Roundup® Hybridization System (RHS). The invention also provides a Relative Development Scale useful for monitoring and determining reproductive development in maize that reconciles developmental differences across various maize varieties. This is useful for determining the optimal timing of a treatment regimen in which tassel development stage is an important factor, including various methods in making hybrid seed.
    Type: Grant
    Filed: January 8, 2020
    Date of Patent: September 13, 2022
    Assignee: MONSANTO TECHNOLOGY, LLC
    Inventors: Paul C. C. Feng, Agustin E. Fonseca, Carl W. Garnaat, Oscar Heredia, Jintai Huang, Rebecca A. Kelly, Youlin Qi, Martin A. Stoecker
  • Publication number: 20210207162
    Abstract: The invention provides recombinant DNA molecules that are unique to maize event MON87429 and transgenic maize plants, maize plant parts, maize seeds, maize cells, and agricultural products containing maize event MON87429 as well as methods of using and detecting maize event MON87429. Transgenic maize plants containing maize event MON87429 exhibit tolerance to inhibitors of acetyl CoA carboxylase (ACCase) in the aryloxyphenoxy propionate (FOP) group, synthetic auxins, inhibitors of glutamine synthetase, and inhibitors of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).
    Type: Application
    Filed: January 12, 2021
    Publication date: July 8, 2021
    Inventors: Christine M. Ellis, Michael E. Goley, Jintai Huang, Tracy E. Klingaman, Clayton T. Larue, Youlin Qi, Oscar C. Sparks, Brook M. Van Scoyoc, Heping Yang
  • Patent number: 10920239
    Abstract: The invention provides recombinant DNA molecules that are unique to maize event MON87429 and transgenic maize plants, maize plant parts, maize seeds, maize cells, and agricultural products containing maize event MON87429 as well as methods of using and detecting maize event MON87429. Transgenic maize plants containing maize event MON87429 exhibit tolerance to inhibitors of acetyl CoA carboxylase (ACCase) in the aryloxyphenoxy propionate (FOP) group, synthetic auxins, inhibitors of glutamine synthetase, and inhibitors of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: February 16, 2021
    Assignee: Monsanto Technology LLC
    Inventors: Christine M. Ellis, Michael E. Goley, Jintai Huang, Tracy E. Klingaman, Clayton T. Larue, Youlin Qi, Oscar C. Sparks, Brook M. Van Scoyoc, Heping Yang
  • Publication number: 20200340010
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 29, 2020
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang
  • Publication number: 20200283790
    Abstract: The invention provides novel recombinant DNA molecules, compositions, and methods for selectively regulating the expression of a transcribable polynucleotide molecule or recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides transgenic plants, plant cells, plant parts, seeds, and commodity products comprising such DNA molecules and compositions.
    Type: Application
    Filed: April 9, 2020
    Publication date: September 10, 2020
    Inventors: Jintai Huang, Youlin Qi, Heping Yang, Yuanji Zhang
  • Patent number: 10704057
    Abstract: The invention provides novel recombinant DNA molecules, compositions, and methods for selectively regulating the expression of a transcribable polynucleotide molecule or recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides transgenic plants, plant cells, plant parts, seeds, and commodity products comprising such DNA molecules and compositions.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: July 7, 2020
    Assignee: Monsanto Technology LLC
    Inventors: Jintai Huang, Youlin Qi, Heping Yang, Yuanji Zhang
  • Publication number: 20200205361
    Abstract: The invention provides transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products derived from event MON 87427. The invention also provides nucleotides specific for transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products comprising nucleotides specific for transgenic maize event MON 87427. The invention also provides methods related to transgenic maize event MON 87427 and to the Roundup® Hybridization System (RHS). The invention also provides a Relative Development Scale useful for monitoring and determining reproductive development in maize that reconciles developmental differences across various maize varieties. This is useful for determining the optimal timing of a treatment regimen in which tassel development stage is an important factor, including various methods in making hybrid seed.
    Type: Application
    Filed: January 8, 2020
    Publication date: July 2, 2020
    Inventors: Paul C. C. Feng, Agustin E. Fonseca, Carl W. Garnaat, Oscar Heredia, Jintai Huang, Rebecca A. Kelly, Youlin Qi, Martin A. Stoecker
  • Patent number: 10689667
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: June 23, 2020
    Assignee: Monsanto Technology LLC
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang
  • Patent number: 10561083
    Abstract: The invention provides transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products derived from event MON 87427. The invention also provides nucleotides specific for transgenic maize event MON 87427 and plants, plant cells, seeds, plant parts, and commodity products comprising nucleotides specific for transgenic maize event MON 87427. The invention also provides methods related to transgenic maize event MON 87427 and to the Roundup® Hybridization System (RHS). The invention also provides a Relative Development Scale useful for monitoring and determining reproductive development in maize that reconciles developmental differences across various maize varieties. This is useful for determining the optimal timing of a treatment regimen in which tassel development stage is an important factor, including various methods in making hybrid seed.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: February 18, 2020
    Assignee: Monsanto Technology LLC
    Inventors: Paul C. C. Feng, Agustin E. Fonseca, Carl W. Garnaat, Oscar Heredia, Jintai Huang, Rebecca A. Kelly, Youlin Qi, Martin A. Stoecker
  • Publication number: 20190241903
    Abstract: The invention provides recombinant DNA molecules that are unique to maize event MON87429 and transgenic maize plants, maize plant parts, maize seeds, maize cells, and agricultural products containing maize event MON87429 as well as methods of using and detecting maize event MON87429. Transgenic maize plants containing maize event MON87429 exhibit tolerance to inhibitors of acetyl CoA carboxylase (ACCase) in the aryloxyphenoxy propionate (FOP) group, synthetic auxins, inhibitors of glutamine synthetase, and inhibitors of 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS).
    Type: Application
    Filed: January 28, 2019
    Publication date: August 8, 2019
    Inventors: Christine M. Ellis, Michael E. Goley, Jintai Huang, Tracy E. Klingaman, Clayton T. Larue, Youlin Qi, Oscar C. Sparks, Brook M. Van Scoyoc, Heping Yang
  • Publication number: 20180030474
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Application
    Filed: October 5, 2017
    Publication date: February 1, 2018
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang
  • Patent number: 9816106
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: November 14, 2017
    Assignee: Monsanto Technology LLC
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang
  • Publication number: 20170029841
    Abstract: The invention provides novel recombinant DNA molecules, compositions, and methods for selectively regulating the expression of a transcribable polynucleotide molecule or recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides transgenic plants, plant cells, plant parts, seeds, and commodity products comprising such DNA molecules and compositions.
    Type: Application
    Filed: July 14, 2016
    Publication date: February 2, 2017
    Inventors: Jintai Huang, Youlin Qi, Heping Yang, Yuanji Zhang
  • Publication number: 20160208283
    Abstract: The invention provides methods and compositions for selectively suppressing the expression of a recombinant protein in a male reproductive tissue of a transgenic plant. The invention also provides methods and compositions for inducing male sterility in a transgenic plant. Plants, plant cells, plant parts, seeds, and commodity products including such compositions are aspects of the invention.
    Type: Application
    Filed: May 22, 2015
    Publication date: July 21, 2016
    Applicant: Monsanto Technology LLC
    Inventors: Jintai Huang, Sergey Ivashuta, Youlin Qi, Barbara Elizabeth Wiggins, Yuanji Zhang